Eyewitness News
Local News
Weather
Eyewitness Sports
HealthBeat
Call For Action
Investigators
Technology
Entertainment
Community
What's On WPRI
What's On Fox
Feedback
Contests
Station Info
Online Store



MARKETPLACE:  Auto | Jobs | Personals | Yellow Pages  March 13, 2004
LIFESTYLE: 
House & Home | Money | Pets | Recipes | Relationships | Travel | Weddings
Drug Reduces Fractures
Email to a Friend Printer Friendly Version  

(Ivanhoe Newswire) -- A drug for women with osteoporosis appears to be effective in reducing the risk for a vertebral fracture, according to new research. The study reports the drug strontium ranelate can reduce the risk of breaking a bone in the vertebral column by 49 percent.

Vertebral fractures are a serious consequence of osteoporosis. Such a break can lead to acute and chronic back pain, spinal deformity and hip fracture. An early study found strontium ranelate reduces the risk of vertebral fractures and increases bone mineral density. This happens because the drug, taken orally, increases bone formation and decreases bone resorption. Researchers in France conducted a larger study to compare the drug to placebo in postmenopausal women with osteoporosis.

The study included 1,649 postmenopausal women with osteoporosis and who suffered at least one vertebral fracture. The women received either the drug strontium ranelate or a placebo daily for three years. Participants were also given calcium and vitamin D supplements. Vertebral radiographs were done each year and measurements of bone mineral density were performed every six months.

Researchers report new vertebral fractures occurred in fewer patients in the strontium ranelate group than in the placebo group. Specifically, patients on the drug had 49-percent reduced risk in the first year of treatment and a 41-percent reduction during the three-year study. Study authors also report at the end of the study the women on the drug had an increase in their bone mineral density including a 14.4 percent increase at the lumbar spine and 8.3 percent at the femoral neck.

Investigators conclude strontium ranelate given orally each day appears to reduce the risk of vertebral fractures rapidly, effectively and safely among postmenopausal women with osteoporosis.

This article was reported by Ivanhoe.com, who offers Medical Alerts by e-mail every day of the week. To subscribe, go to: http://www.ivanhoe.com/newsalert/.

SOURCE: New England Journal of Medicine, 2004;350:459-468

Health News | Health Encyclopedia | Quizzes and Tools | Women's Health | Men's Health | Children's Health | Seniors' Health | Diet, Fitness and Self Image | Sex and Relationships
Health Encyclopedia: Women's Health
Dilatation And Curettage (D and C)
Breast Calcifications
Tubal Ligation
Vaginal Prolapse
Postpartum Depression
Myomectomy
Prenatal Care
Prolapsed Uterus
Ovarian Cysts
Toxoplasmosis
Women's Health News
Mammography Recall Guideline Needs Second Look
HRT's Benefits for Colon Cancer in Doubt
Scientists Complete Chicken Genome
NIH Halts HRT Trial
The Fallout From Breast Cancer Therapy
When Breast-Feeding Moms Return to Work
Weight Gain Leads to Breast Cancer
Prophylactic Mastectomies Reduce Cancer Risk
Procedure Helps Women at Risk for Cancer
Halting Damage of Hysterectomy

Home Care Guide
Checklists, cleaning tips and more.
Job Market News
Find a better job today.
It's Tax Time!
Get your questions answered.
Got Heartburn?
Learn how to treat GERD.
Send questions and comments about this website to the .
All content © Copyright 2004 WorldNow, WPRI, WNAC and Associated Press. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.